Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC OTSSP167 hydrochloride | 1431698-10-0 | 99.78% | 523.88 | 50 MG
SDP

Catalog No. 5000364265
Encompass_Preferred

OTSSP167 (OTS167) hydrochloride is a highly potent and ATP-competitive MELK inhibitor with an IC50 value of 0.41 nM. For research use only, this product is not sold to patients. It inhibits the growth of various cancer cell lines including lung (A549), breast (T47D, DU4475), prostate (22Rv1), and bladder (HT1197) with IC50 values ranging from 2.3 to 97 nM. OTSSP167 can also abrogate the mitotic checkpoint and disrupt MCC and MCC-APC/C interaction in MCF7 cells.

  • Highly potent and ATP-competitive MELK inhibitor.
  • Exhibits strong in vitro activity with an IC50 of 0.41 nM.
  • Inhibits the growth of multiple cancer cell lines (lung, breast, prostate, bladder).
  • Can abrogate the mitotic checkpoint and disrupt MCC/MCC-APC/C interaction.
  • Causes GFP-MELK localization to the cell cortex in prometaphase cells.
  • Results in tumor growth inhibition in xenograft mouse models.

Catalog No. 50-003-64265 Supplier Medchemexpress LLC Supplier No. 50MGHY15512A
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

OTSSP167 (OTS167) hydrochloride is a highly potent and ATP-competitive MELK inhibitor with an IC50 value of 0.41 nM. For research use only, this product is not sold to patients. It inhibits the growth of various cancer cell lines including lung (A549), breast (T47D, DU4475), prostate (22Rv1), and bladder (HT1197) with IC50 values ranging from 2.3 to 97 nM. OTSSP167 can also abrogate the mitotic checkpoint and disrupt MCC and MCC-APC/C interaction in MCF7 cells.

  • Highly potent and ATP-competitive MELK inhibitor.
  • Exhibits strong in vitro activity with an IC50 of 0.41 nM.
  • Inhibits the growth of multiple cancer cell lines (lung, breast, prostate, bladder).
  • Can abrogate the mitotic checkpoint and disrupt MCC/MCC-APC/C interaction.
  • Causes GFP-MELK localization to the cell cortex in prometaphase cells.
  • Results in tumor growth inhibition in xenograft mouse models.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.